Motion Control Resources
National Instruments Names MoviMED a Vision Specialty Alliance Partner
National Instruments Posted 06/07/2013
MoviMED, a motion and vision system integration specialist with more than 45 combined man-years of experience with NI products, has been named a Vision Specialty Alliance Partner.
MoviMED Custom Imaging Solutions has been named a Vision Specialty Alliance Partner by National Instruments. The company received this designation for its specialized machine vision capabilities, and for an established track record of delivering leading-edge, multifaceted machine vision and integrated motion solutions to a diverse client base in a wide range of industries.
MoviMED is proud to announce the Vision Specialty Alliance Partner designation, and is honored to have been recognized by National Instruments as a top-tier solutions provider. This designation further underscores MoviMED’s position as a leader in the global machine vision marketplace.
“MoviMED definitely goes out of their way to provide valuable, cost-effective solutions for customers, and the company works exceptionally hard to ensure that customers are completely satisfied,” said Gregory Smith, area sales manager at National Instruments. "MoviMED founder and CEO, Markus Tarin, has put together a very highly skilled team of engineers within his company... and they are definitely a ‘go-to’ organization for machine vision automation. I highly recommend MoviMED.”
“We believe the National Instruments Vision Specialty Partner title is the direct consequence of 13 successful years of custom machine vision integration,” said Markus Tarin, CEO at MoviMED. “Our customer-driven, start-to-finish approach enables us to deliver targeted, quality solutions both to our OEM partners, who are building vertically-integrated products for specific industries, and for our specialty customers, who require complex, customized motion and vision applications. Incorporating National Instruments products into our projects has always made good business sense for us, and we anticipate continuing this successful formula in the years ahead.”